As noted by Hausners team: "No clinically significant pharmacokinetic or pharmacodynamic interactions were identified This suggests that no dose adjustments should be required when semaglutide is administered concomitantly with these medications." Other findings support this consistency
A few more sips: In case you are interest (because you know I was), she references one of her own papers recently published where she followed her own set of rules
GHK-Cu topical: 1 %3 % for skin, 0.5 % for scalp AHK-Cu topical: 0.05 %0.1 % is standard in most hair serums - note this is much lower than GHK-Cu percentages Injectable AHK-Cu: less well characterised
These hormones slow down digestion, which is how they help you feel full, but this slow-down can sometimes lead to nausea, bloating, or indigestion
Novi's documents disclose the 3-month commitment structure, the collections language, and the arbitration terms